Page last updated: 2024-08-25

methyl fluorone black and 9-hydroxyphenylfluoron

methyl fluorone black has been researched along with 9-hydroxyphenylfluoron in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Andrew McCammon, J; Hess, TN; Jones, V; McNeil, MR; Wang, Y; Zhou, JZ	1
Choowongkomon, K; Eurtivong, C; Jiwacharoenchai, N; Niwetmarin, W; Ruchirawat, S; Saruengkhanphasit, R; Seetaha, S	1

Other Studies

2 other study(ies) available for methyl fluorone black and 9-hydroxyphenylfluoron

Article	Year
Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening. Bioorganic & medicinal chemistry letters, 2011, Dec-01, Volume: 21, Issue:23 Topics: Antitubercular Agents; Binding Sites; Computer-Aided Design; Crystallography, X-Ray; Drug Discovery; Enzyme Activation; Enzyme Inhibitors; Inhibitory Concentration 50; Models, Molecular; Mycobacterium tuberculosis; Sugar Alcohol Dehydrogenases	2011
Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation. Bioorganic & medicinal chemistry letters, 2022, 02-15, Volume: 58 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; ErbB Receptors; Heterocyclic Compounds; Humans; Molecular Docking Simulation; Molecular Structure; National Cancer Institute (U.S.); Oxygen; Protein Kinase Inhibitors; Structure-Activity Relationship; United States; Xanthenes	2022

Article

Year

Novel inhibitors of Mycobacterium tuberculosis dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD) identified by virtual screening.

Bioorganic & medicinal chemistry letters, 2011, Dec-01, Volume: 21, Issue:23

Topics: Antitubercular Agents; Binding Sites; Computer-Aided Design; Crystallography, X-Ray; Drug Discovery; Enzyme Activation; Enzyme Inhibitors; Inhibitory Concentration 50; Models, Molecular; Mycobacterium tuberculosis; Sugar Alcohol Dehydrogenases

2011

Discovery of potent antiproliferative agents from selected oxygen heterocycles as EGFR tyrosine kinase inhibitors from the U.S. National Cancer Institute database by in silico screening and bioactivity evaluation.

Bioorganic & medicinal chemistry letters, 2022, 02-15, Volume: 58

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; ErbB Receptors; Heterocyclic Compounds; Humans; Molecular Docking Simulation; Molecular Structure; National Cancer Institute (U.S.); Oxygen; Protein Kinase Inhibitors; Structure-Activity Relationship; United States; Xanthenes

2022